DENTSPLY SIRONA (NASDAQ:XRAY) Given Outperform Rating at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report)'s stock had its "outperform" rating reissued by equities researchers at Barrington Research in a report released on Tuesday,Benzinga reports. They currently have a $21.00 price objective on the medical instruments supplier's stock. Barrington Research's price objective suggests a potential upside of 31.00% from the company's previous close.

XRAY has been the subject of several other research reports. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Sunday, July 13th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Piper Sandler dropped their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Finally, Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Ten research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and an average price target of $19.60.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded down $0.43 during trading on Tuesday, reaching $16.03. The stock had a trading volume of 3,278,545 shares, compared to its average volume of 2,844,030. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $27.95. The business's 50-day moving average price is $16.05 and its 200 day moving average price is $16.22. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. The stock has a market capitalization of $3.19 billion, a PE ratio of -3.53, a P/E/G ratio of 1.20 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. DENTSPLY SIRONA's quarterly revenue was down 7.8% compared to the same quarter last year. As a group, equities analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently made changes to their positions in XRAY. Proficio Capital Partners LLC bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $422,000. HighTower Advisors LLC grew its holdings in shares of DENTSPLY SIRONA by 41.3% in the 4th quarter. HighTower Advisors LLC now owns 24,480 shares of the medical instruments supplier's stock valued at $465,000 after buying an additional 7,152 shares during the period. Envestnet Portfolio Solutions Inc. grew its holdings in shares of DENTSPLY SIRONA by 82.9% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,901 shares of the medical instruments supplier's stock valued at $302,000 after buying an additional 7,206 shares during the period. Signaturefd LLC grew its holdings in shares of DENTSPLY SIRONA by 513.3% in the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after buying an additional 3,706 shares during the period. Finally, Xponance Inc. grew its holdings in shares of DENTSPLY SIRONA by 7.3% in the 4th quarter. Xponance Inc. now owns 33,034 shares of the medical instruments supplier's stock valued at $627,000 after buying an additional 2,235 shares during the period. Institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.